Dow Up 0.76% Nasdaq Up 0.69%

Pacira Pharmaceuticals, Inc. (PCRX)

-NasdaqGS
106.44 Up 2.31(2.22%) Oct 24, 4:00PM EDT
Prev Close:104.13
Open:103.97
Bid:91.00 x 100
Ask:N/A
1y Target Est:110.50
Beta:1.63
Next Earnings Date:30-Oct-14PCRX Earnings announcement
Day's Range:102.78 - 106.95
52wk Range:45.68 - 109.94
Volume:288,912
Avg Vol (3m):460,391
Market Cap:3.82B
P/E (ttm):N/A
EPS (ttm):-1.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

┬╗ More Headlines for PCRX

Comparison

Symbol% ChgMkt Cap
PCRXUp 2.22%3.82B
ALKSUp 1.39%6.69B
DRRXUp 1.46%155.12M

Key Statistics

Forward P/E (1 yr):41.26
P/S (ttm):26.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.19
Quarterly EPS Est (Sep-14) :0.10
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures pharmaceutical products primarily for use in hospitals and ambulatory surgery centers worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback